Journal of Mind and Medical Sciences
Volume 6 | Issue 2

Article 21

2019

Laparoscopic resection of gastric GISTs. Where do
we stand now? A single-centered experience
Iulian Slavu
Lucian Alecu
Adrian Tulin
Dana L. Stanculeanu
Cornelia Nitipir

Follow this and additional works at: https://scholar.valpo.edu/jmms
Part of the Gastroenterology Commons, Oncology Commons, and the Surgery Commons

Recommended Citation
Slavu, Iulian; Alecu, Lucian; Tulin, Adrian; Stanculeanu, Dana L.; and Nitipir, Cornelia (2019) "Laparoscopic resection of gastric
GISTs. Where do we stand now? A single-centered experience," Journal of Mind and Medical Sciences: Vol. 6 : Iss. 2 , Article 21.
DOI: 10.22543/7674.62.P334339
Available at: https://scholar.valpo.edu/jmms/vol6/iss2/21

This Research Article is brought to you for free and open access by ValpoScholar. It has been accepted for inclusion in Journal of Mind and Medical
Sciences by an authorized administrator of ValpoScholar. For more information, please contact a ValpoScholar staff member at scholar@valpo.edu.

https://scholar.valpo.edu/jmms/
https://proscholar.org/jmms/
ISSN: 2392-7674

J Mind Med Sci. 2019; 6(2): 334-339
doi: 10.22543/7674.62.P334339

Received for publication: February 5, 2019
Accepted: May 7, 2019

Research article
Laparoscopic resection of gastric GISTs.
Where do we stand now? A single-centered
experience
Iulian Slavu1, Lucian Alecu2, Adrian Tulin2, Dana L. Stanculeanu3, Cornelia Nitipir4
1

Clinical Emergency Hospital Bucharest, Department of General Surgery, Bucharest, Romania
Agrippa Ionescu Clinical Emergency Hospital, Department of General Surgery, Bucharest, Romania
3
Al. Trestioreanu Institute of Oncology, The Oncology Clinic, Bucharest, Romania
4
Elias University Emergency Hospital, The Oncology Clinic, Bucharest, Romania
2

Abstract

Introduction. Gastrointestinal stromal tumors (GISTs) represent a rare type of gastrointestinal
neoplasms. Resection with negative margins has been established as a mainstay treatment, but
laparoscopic resections are still open to debate. Material and method. This retrospective study was
conducted at a single institution, with data collected over 2 years (01.01.2017-01.01.2019). The
variables examined were age, tumor location with regard to the gastric wall, the results of the
intraoperative endoscopy, intraoperative and postoperative complications, the surgical technique,
and histopathological reports. Results. We identified 12 relevant cases, of which 8 were females
and 4 males. The average tumor diameter was 2.3 cm. The majority of the lesions were located on
the anterior gastric wall (8 cases), on the small curvature (2 cases), and in the pyloric region (2
cases). Intraoperative endoscopy was performed successfully in 10 cases in order to identify the
lesions and guide the resection. The average operative time was 120 minutes and the average
hospital stay was 5 days. The gastric wall with the lesion was resected using an Ultrasonic device,
a 2-cm oncological safety margin was preserved. Conclusion. Complete surgical resection
independent from the tumor size represents the current optimal treatment. From a surgical point of
view, these tumors must be considered malignant and the surgeon must respect principles of
oncological surgery. Maintaining tumor integrity at dissection is critical for the patient’s long-term
prognosis. Laparoscopic resection independent of the tumor size is feasible.
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Highlights

✓ Complete surgical resection independent of tumor size represents the current optimal
treatment of GISTs.

GIST, gastric, laparoscopy, technique

✓ Laparoscopic resection is possible, although the surgeon’s experience along with careful
patient selection plays a critical role.
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Introduction
Mesenchymal gastrointestinal tumors or GISTs are a
particular subtype of gastrointestinal tumors (1). Although
these tumors have historically been considered benign or
borderline malignant, with the recent evolution of
immunohistochemical and histopathological diagnostic
methods, GISTs have been redefined as malignant tumors,
meaning that the oncological principles of resection must
be respected (2).
Regarding their location, these tumors can develop
anywhere in the gastrointestinal tract but are most
commonly identified at the gastric level in up to 60% of the
cases. The stomach is more accessible for endoscopy than
the small intestine which this may account for its increased
incidence (3). Another cause may be the embryological
origin of these tumors that evolve from the Cajal cells –
which represent the pacemaker of the digestive tract
located at the level of the gastric fornix (3).

Our study aimed to reevaluate the oncological outcome
and technique when resecting gastric GISTs, based on
experience from our clinic. Due to widespread endoscopic
evaluations, gastric tumors are identified in the early stages
limited to the submucosa, with no expression at the level
of the serosa. Thus, they are difficult to identify and resect
using oncological safety margins. Through this study, we
aimed to evaluate the use of intraoperative endoscopy in
order to identify these tumors and guide the resection
process.

Materials and Methods
The study is a retrospective analysis conducted in a
single institution, with data obtained over a 2-year period
(01.01.2017-01.01.2019). Variables examined were age,
tumor location with regard to the gastric wall, results of the
intraoperative endoscopy, intraoperative and postoperative
complications, surgical technique, and histopathological

The degree of malignancy of these tumors is given by

reports. In addition, the efficacy of the intraoperative

the tumor macroscopic characteristics (size), but also by
the cells themselves, i.e. the number and frequency of
mitoses, or the degree of differentiation (4).

endoscopical procedure in identifying the tumors and
guiding the resection was evaluated. The results of the 1year evaluation, which included a CT with contrast media
and upper endoscopy, were also examined. All patients
were operated on laparoscopically. Tumor size did not
represent a contraindication.

Taking these factors into consideration, the surgeon
must avoid rupturing the tumor capsule during surgery and
maintain negative resection margins of 1-2 cm.
Lymphadenectomy is not required when a GIST tumor is
identified, since tumor cells rarely disseminate through the
lymphatic system (5). Given these recommendations, if a
gastric GIST is confirmed, a wedge resection can be
performed – which is a straight-forward intervention. Since
laparoscopy has evolved and increasingly complex
interventions are now being performed, the question
regarding the application of this technique to gastric GISTs

Results
We identified 12 cases, of which 8 were females and 4
males. Age at diagnosis ranged between 32 and 64 years.
Common symptoms were gastric bleeding, anemia, and
weight loss.

has arisen. (6). Several authors such as Joensuu et al. and
Nguyen et al. have confirmed the feasibility of this
intervention, which implies a full-thickness resection of the
gastric wall through a minimally invasive approach (7, 8).
Also, a large-scale meta-analysis has been published,
which confirms the aforementioned results (9, 10).
Regarding the size of the tumors, laparoscopy has been
recommended only for tumors under 2 cm due to the high
risk of rupture and contamination at dissection, but this
approach has not been supported by all authors. De
Vogelaere et al. demonstrated, on a group of 31 patients,
that the size of the tumor does not impact the relapse rate
for laparoscopic operations (11, 12).

Figure 1. Large GIST (8cm) located on the anterior
gastric wall (arrow).
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Figure 2. Small gastric GIST (circle) located
between the mucosal folds of the stomach,
identified through intraoperative endoscopy.

Figure 3. An aspect of gastrotomy after the
resection of a GIST identified through the
preoperative endoscopic instillation of methylene
blue.

The average tumor diameter was 2.3 cm, with a
maximum of 15 cm and a minimum of 1.7 cm (Figure no.
4). Gastrostomy has always been sutured with a double
layer Vicryl wire. The integrity of the suture line was
verified intraoperatively with the use of methylene blue,
which was administered through the nasogastric tube.
The intraoperative laparoscopic exploration did not
reveal peritoneal metastasis, which correlated with the
preoperative investigations. Regarding the location of the
tumor, the majority of the lesions were located on the
anterior gastric wall (8 cases), on the small curvature (2
cases), and in the pyloric region (2 cases). Some of the
tumors were large and had an important expression on the
level of the gastric serosa which made them easily
identifiable, as seen in Figure 1. In other cases, the tumors
were limited to the submucosa, thus being nearly
impossible to identify laparoscopically. Frequently, tumors
are located between the gastric mucosal folds. In such
cases, intraoperative endoscopy is very helpful.
In our series, intraoperative endoscopy was performed
successfully in 10 cases in order to identify the lesions and
guide the resection (Figure no. 1). In 4 cases, preoperative
endoscopic staining was used to identify the lesion (Figure
no 2). Endoscopy proved helpful in identifying the small
lesions located in the submucosa, which had no expression
at the level of the serosa.
Great care was taken at dissection to avoid
intraoperative tumor ruptures. The average operative time
was 120 minutes, but depended on whether gastric suture
was done with a stapler or manually. All patients had a
contrast barium Rx on the third day to identify any
potential leakage. There was none.
All patients had a drainage tube placed in the Morisson
pouch and which was removed on the second postoperative
day, with no complications. The average hospital stay was
5 days. All patients had a nasogastric tube placed
intraoperatively which was removed on the third day. The
gastric wall with the lesion was resected using an
Ultrasonic device, with a 2-cm oncological safety margin.
All resections were R0. A one-year reevaluation through
endoscopy and CT did not reveal any sign of relapse.
Regarding the postoperative complications, we
encountered one case of intraluminal bleeding, which was
terminated with clips applied endoscopically on the third
postoperative day.

Discussions
Figure 4. The aspect of a large gastric GIST after
resection with safety margins of 2 cm. The surface
is round, smooth with no macroscopic signs of
invasion.
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The first description of a gastrointestinal stromal tumor
was published in 1983 by Clar and Mazur who defined it
as a new type of sarcoma (13). Although GISTs were
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initially considered benign, they are now considered
malignant, although they rarely have a diffuse infiltrating
evolution in the organs in which they originate. These
tumors rarely lead to lymphatic metastasis (14, 15).
Due to these characteristics, local excision is
considered sufficient as a final treatment. Some authors
even recommend enucleation for small tumors. We,
however, do not recommend this technique in laparoscopy
due to the rigidity of the instruments which may perforate
and disseminate the tumor cells in the peritoneal cavity.
Rupturing the capsule of the tumor can have catastrophic
results for the patient, so one should avoid manipulating
the tumor directly during surgery and should grasp only the
tissue around the tumor. Also, an endo-bag is mandatory
when extracting the specimen so as not to contaminate the
abdominal wall (16).
As demonstrated in our series of patients, a
laparoscopic wedge resection is technically feasible,
ensuring good oncological results without affecting the
functionality of the gastric tube (17). Due to the constant
advancements in stapler technology and laparoscopic
gastric surgery, this technique has also been recommended
by other authors (18, 19). However, depending on the
tumor location, this technique is not always feasible; small
tumors located on the anterior gastric wall are usually ideal
for this resection. In our series, when a wedge resection
could not be performed, a gastric wall resection using an
ultrasonic device with subsequent suturing of the defect
using a double layer, resorbable running suture gave the
best results with no postoperative complications. It did,
however, extend operative time considerably.
Regarding the size of the tumors, past practice avoided
laparoscopy when tumor size exceeded 2 cm (20). From
our standpoint, if the laparoscopic instruments are
available and the surgeon has the necessary experience, the
size of the tumor should not represent a contraindication
for laparoscopy. As demonstrated in our study, tumors up
to 8-10 cm were resected laparoscopically with good
oncological and functional outcomes. Multiple studies in
the literature have confirmed its feasibility, although the
NCCN guidelines and the European ESMO guidelines do
not recommend laparoscopy for resection of large GIST
tumors (21). Consistent with our perspective, Ye et al.
also note that the surgeon’s experience is paramount when
selecting to laparoscopically operate on a GIST in order to
avoid capsule tears and peritoneal spillage of the tumor
cells (22). Perhaps in the near future, the guidelines will
adapt to the experience gained by surgeons in the field of
laparoscopy (23-25).

Some studies have shown good results with handassisted laparoscopic resections, to gently manipulate the
tumor and dissect it from the surrounding structures. This
technique was not used on the patients in our series since
the tumors were dissected safely only with the laparoscopic
instruments. Regarding the oncological safety margins, our
resections involve a 1-2cm distance from the tumor,
although research has demonstrated that the rate of
recurrence does not seem to be influenced by the resection
distance and varies rather according to the size of the
tumor. Keeping these aspects in mind, the surgeon must
obtain a clear macroscopic resection without
lymphadenectomy (26). Although our sample size was
small, our group had a postoperative survival rate of 100 %
at 1 year.
When smaller tumors are encountered, intraoperative
endoscopy is helpful in guiding the surgeon to the location
of the lesion. For example, we encountered gastric
submucosal tumors of 1-2cm, with no clear expression at
the level of the serosa. Endoscopy is paramount in these
situations. If one does not identify the lesion, the use of
staples should be avoided and a circumferential resection
under the direct guidance of the endoscopist is
recommended to avoid the rupture of the tumor with
subsequent spillage. In four cases, we used the preoperative
marking of the lesion with methylene blue, but the
endoscopist had to pay close attention to the depth of the
gastric layers and the quantity when administering the
substance, since it can always dissipate in a large area of
the gastric wall (27, 28). This makes it difficult for the
surgeon to correctly resect the area where the tumor is
located.
Protocols for postoperative monitoring are open to
discussion, since the frequency and the instruments used
vary according to several criteria. Recent data tend to
ignore absolute definitions of benign or malignant.
Moreover, we noticed that this field is continuously
changing (29): the tumors were initially defined as benign,
then malignant, and now benign or malignant, with
differentiating factors being their size (above 10 cm) and
rate of division (30). A high index of replication increases
the mortality rate of up to 50% when compared to low
mitotic tumors (30).
A high mitotic index is defined as 10 mitoses per 50
HPF (high power fields), and this index predicts the
recurrence rate. Thus, due to the ongoing redefinition of
these tumors and reclassifications, no clear follow-up
protocol has been standardized. Therefore, since these
tumors have an unpredictable evolution, long-term
monitoring is crucial, from our point of view. After
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surgery, we evaluated the patients at 6 months when
endoscopy was done, with an annual CT of the thorax,
abdomen, and pelvis in the first 2 years. Nowain et al. noted
that most recurrences usually evolved within this time
period (31).
The global overall survival at 5 years after laparoscopic
resection reaches 92%-93%, while the 3-year survival rate
is 96% after the laparoscopic resection (32).

Conclusions
Knowledge regarding GISTs is continuously evolving.
Complete surgical resection independent of tumor size
represents the current optimal treatment. These tumors
must be considered malignant from a surgical standpoint
and the surgeon must respect the oncological surgery
principles.
Maintaining tumor integrity at dissection is critical for
the patient’s long-term prognosis. Laparoscopic resection
independent of the tumor size is possible, although the
surgeon’s experience along with careful patient selection
plays a critical role. Currently, no clear post-operative
follow-up protocol exists, but long-term survival is good.
The rate of tumor relapse varies according to the tumor size
and mitotic index.
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